[1]
Muhamad Luthfi Asyhar et al. 2026. Sodium–Glucose Cotransporter-2 (SGLT-2) Inhibitors for Slowing the Progression of Chronic Kidney Disease: A Systematic Review of Randomized Controlled Trials and Primary Studies. The International Journal of Medical Science and Health Research. 48, 4 (Jul. 2026), 352–437. DOI:https://doi.org/10.70070/7n0yfm95.